IPO registrations (S-1, F-1) · Registrants
EQRx, Inc.
- SEC CIK
- 1843762 · filings on EDGAR ↗
- Former names
- CM Life Sciences III Inc. (2021–2021)
- Registration
- Form S-1, first filed 2021-02-25, last 2021-12-21; 2 initial registrations, 1 amendment
- Outcome
- Final prospectus filed 2021-04-08; declared effective 2021-04-06
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Business address
- 50 HAMPSHIRE STREET, Cambridge, MA 02139
- EIN
- 86-1691173
- EDGAR entity type
- operating
- Insiders and CEO pay
- EQRx, Inc. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2021-04-08, an initial public offering)
- Shares sold
- 48,000,000
- Gross proceeds
- $480,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CMLT
- Lead underwriters
- Jefferies; Cowen
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: CM Life Sciences III Inc. EXACT (CIK (EXACT))
- Person page: Marc L Andreessen Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
Filings 14
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-02-25 | S-1 | S-1 (registration) | CM Life Sciences III Inc. | 0001213900-21-011439 ↗ |
| 2021-03-25 | S-1/A | S-1/A (amendment) | CM Life Sciences III Inc. | 0001213900-21-017805 ↗ |
| 2021-04-06 | S-1MEF | S-1MEF (added securities) | CM Life Sciences III Inc. | 0001213900-21-020491 ↗ |
| 2021-04-06 | EFFECT | EFFECT (declared effective) | CM Life Sciences III Inc. | 9999999995-21-001298 ↗ |
| 2021-04-08 | 424B4 | 424B4 (final prospectus) | CM Life Sciences III Inc. | 0001213900-21-020818 ↗ |
| 2021-12-01 | EFFECT | EFFECT (declared effective) | CM Life Sciences III Inc. | 9999999995-21-004524 ↗ |
| 2021-12-21 | S-1 | S-1 (registration) | EQRx, Inc. | 0001213900-21-066498 ↗ |
| 2021-12-23 | EFFECT | EFFECT (declared effective) | EQRx, Inc. | 9999999995-21-004818 ↗ |
| 2022-03-28 | EFFECT | EFFECT (declared effective) | EQRx, Inc. | 9999999995-22-000733 ↗ |
| 2023-03-03 | EFFECT | EFFECT (declared effective) | EQRx, Inc. | 9999999995-23-000514 ↗ |
| 2023-03-03 | EFFECT | EFFECT (declared effective) | EQRx, Inc. | 9999999995-23-000515 ↗ |
| 2023-11-17 | EFFECT | EFFECT (declared effective) | EQRx, Inc. | 9999999995-23-003369 ↗ |
| 2023-11-17 | EFFECT | EFFECT (declared effective) | EQRx, Inc. | 9999999995-23-003373 ↗ |
| 2023-11-17 | EFFECT | EFFECT (declared effective) | EQRx, Inc. | 9999999995-23-003374 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-03-25 | S-1/A | registration statement | $10.00 | 40,000,000 | $400,000,000 | Nasdaq CMLT | 2 | primary document; price sentence, shares headline, proceeds table, cover names 2 | document ↗ | |
| 2021-04-08 | 424B4 | final prospectus | $10.00 | 48,000,000 | $480,000,000 | Nasdaq CMLT | 2 | primary document; price sentence, shares headline, proceeds table, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Casdin Eli | Director; Director,Officer,TenPercentOwner; Director,TenPercentOwner; TenPercentOwner | Chief Executive Officer; Officer (CEO) | 7 | 2021–2023 | |
| C-LSH III LLC | Director,TenPercentOwner; TenPercentOwner | 2 | 2021 | ||
| CMLS Holdings III LLC | Director,TenPercentOwner; TenPercentOwner | 2 | 2021 | ||
| Emes Brian | Officer | CFO and Secretary | 1 | 2021 | |
| HENRY CHRISTIAN O | Director | 1 | 2021 | ||
| Meister Keith A. | Director,TenPercentOwner | 2 | 2021 | ||
| M-LSH III LLC | Director,TenPercentOwner; TenPercentOwner | 2 | 2021 | ||
| Owusu-Kesse Kwame | Director | 1 | 2021 | ||
| ROBINS CHAD M | Director | 1 | 2021 | ||
| ROBINS HARLAN S | Director | 1 | 2021 | ||
| Rodriguez Shaun | Officer | Chief Strategy Officer | 1 | 2021 | |
| Abernethy Amy | Director | 7 | 2021–2023 | ||
| BERNS PAUL L | Director | 5 | 2021–2023 | ||
| Borisy Alexis | Director; Director,Officer | Executive Chairman | 4 | 2021–2023 | |
| GIUSTI KATHRYN E | Director | 5 | 2021–2023 | ||
| Hedrick Eric | Officer | Chief Physician Executive | 4 | 2021–2023 | |
| Horning Sandra | Director | 5 | 2021–2023 | ||
| MEANWELL CLIVE | Director | 5 | 2021–2023 | ||
| MERKSAMER SAMUEL J. | Director | 3 | 2021–2023 | ||
| Nallicheri Melanie | Director,Officer | Chief Executive Officer | 5 | 2021–2023 | |
| Rubin Jami | Officer | Chief Financial Officer | 4 | 2021–2023 | |
| Yeshwant Krishna | Director | 3 | 2021–2023 | ||
| Conde Jorge | Director | 4 | 2021–2023 | ||
| AH Bio Fund II-B, L.P. | TenPercentOwner | 3 | 2021–2023 | ||
| AH Bio Fund III-B, L.P. | TenPercentOwner | 3 | 2021–2023 | ||
| AH Bio Fund III, L.P. | TenPercentOwner | 3 | 2021–2023 | ||
| AH Bio Fund III-Q, L.P. | TenPercentOwner | 3 | 2021–2023 | ||
| AH Bio Fund II, L.P. | TenPercentOwner | 3 | 2021–2023 | ||
| AH Equity Partners Bio III, L.L.C. | TenPercentOwner | 3 | 2021–2023 | ||
| AH Equity Partners Bio II, L.L.C. | TenPercentOwner | 3 | 2021–2023 | ||
| AH Equity Partners LSV II, L.L.C. | TenPercentOwner | 3 | 2021–2023 | ||
| AH Equity Partners LSV I, L.L.C. | TenPercentOwner | 3 | 2021–2023 | ||
| Andreessen Horowitz LSV Fund I-B, L.P. | TenPercentOwner | 3 | 2021–2023 | ||
| Andreessen Horowitz LSV Fund II-B, L.P. | TenPercentOwner | 3 | 2021–2023 | ||
| Andreessen Horowitz LSV Fund II, L.P. | TenPercentOwner | 3 | 2021–2023 | ||
| Andreessen Horowitz LSV Fund II-Q, L.P. | TenPercentOwner | 3 | 2021–2023 | ||
| Andreessen Horowitz LSV Fund I, L.P. | TenPercentOwner | 3 | 2021–2023 | ||
| Andreessen Horowitz LSV Fund I-Q, L.P. | TenPercentOwner | 3 | 2021–2023 | ||
| Andreessen Marc L | TenPercentOwner | 3 | 2021–2023 | person page Fuzzy | |
| HOROWITZ BENJAMIN A | TenPercentOwner | 3 | 2021–2023 | ||
| Ciarimboli Dina | Officer | General Counsel and Secretary | 5 | 2022–2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | EQRx, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Marc L Andreessen | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, MA first:
- Korro Bio, Inc. MA
- ERGO SCIENCE CORP MA
- MILLENNIUM PHARMACEUTICALS INC MA
- ESSENTIAL THERAPEUTICS INC MA
- ARQULE INC MA
- ASCENT PEDIATRICS INC MA
- EPIX Pharmaceuticals, Inc. MA
- PRAECIS PHARMACEUTICALS INC MA
- PARATEK PHARMACEUTICALS INC MA
- PREDIX PHARMACEUTICALS HOLDINGS INC MA
In other datasets, the same topic (Health) in MA:
- Nonprofit: ABBIE M GRIFFIN HOSPITAL FUND (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health